Previous close | 6.16 |
Open | 6.23 |
Bid | 6.25 x 100 |
Ask | 6.33 x 200 |
Day's range | 6.05 - 6.54 |
52-week range | 3.50 - 33.50 |
Volume | |
Avg. volume | 2,852,875 |
Market cap | 50.41M |
Beta (5Y monthly) | 2.54 |
PE ratio (TTM) | N/A |
EPS (TTM) | -17.62 |
Earnings date | 09 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 18.50 |
Extended Partnerships Highlight Phunware's Role in Streamlining Patient and Guest Experiences with Innovative Mobile SolutionsAUSTIN, Texas, April 24, 2024 (GLOBE NEWSWIRE) -- Phunware, Inc. (NASDAQ: PHUN) (the “Company”), the leading provider of patented wayfinding and mobile engagement solutions that enable brands to engage, manage and monetize anyone anywhere, announced today the renewal or extension of several healthcare and hospitality customer contracts. These renewals underscore the value
The heavy selling pressure might have exhausted for Phunware (PHUN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Equillium (EQ), Laird Superfood (LSF), QuantaSing (QSG), Phunware (PHUN) and Arq (ARQ) more than double in the first quarter and are expected to continue their strong performances.